Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
Filing tables
Filing exhibits
Related press release
Associated UROV transcripts
UROV similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following the Registration Statements:
(1) | Registration Statement (Form S-8 No. 333-227593) pertaining to the Urovant Sciences Ltd. 2017 Equity Incentive Plan, as amended and restated, |
(2) | Registration Statement (Form S-8 No. 333-228386) pertaining to the Urovant Sciences Ltd. 2017 Equity Incentive Plan, as amended and restated; |
of our report dated June 14, 2019, with respect to the consolidated financial statements of Urovant Sciences Ltd. included in this Annual Report (Form 10-K) of Urovant Sciences Ltd. for the year ended March 31, 2019.
/s/ Ernst & Young LLP
Irvine, California
June 14, 2019